| 20/04/23 | 07:00:58 | 20 Apr 2023 | | Unaudited Preliminary Results for 2022 |
| 05/04/23 | 07:00:02 | 5 Apr 2023 | | Arecor Appoints Chief Business Officer |
| 22/03/23 | 07:00:02 | 22 Mar 2023 | | FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL |
| 13/03/23 | 16:35:23 | 13 Mar 2023 | | Price Monitoring Extension |
| 13/03/23 | 14:05:22 | 13 Mar 2023 | | Second Price Monitoring Extn |
| 13/03/23 | 14:00:20 | 13 Mar 2023 | | Price Monitoring Extension |
| 13/03/23 | 11:05:38 | 13 Mar 2023 | | Second Price Monitoring Extn |
| 13/03/23 | 11:00:22 | 13 Mar 2023 | | Price Monitoring Extension |
| 13/03/23 | 09:05:41 | 13 Mar 2023 | | Second Price Monitoring Extn |
| 13/03/23 | 09:00:21 | 13 Mar 2023 | | Price Monitoring Extension |
| 01/03/23 | 07:00:12 | 1 Mar 2023 | | ARECOR TO PRESENT SHARESOC WEBINAR |
| 24/02/23 | 16:44:40 | 24 Feb 2023 | | Holding(s) in Company |
| 24/02/23 | 07:00:05 | 24 Feb 2023 | | Notice of Results |
| 16/02/23 | 07:00:05 | 16 Feb 2023 | | Arecor Granted Patents in India and the US |
| 14/02/23 | 07:01:01 | 14 Feb 2023 | | ARECOR STRENGTHENS COLLABORATION WITH PARTNER |
| 30/01/23 | 07:00:04 | 30 Jan 2023 | | Arecor Publishes Data for AT278 in Diabetes Care |
| 19/01/23 | 07:00:05 | 19 Jan 2023 | | BUSINESS UPDATE |
| 12/01/23 | 07:00:03 | 12 Jan 2023 | | ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA |
| 04/01/23 | 07:00:04 | 4 Jan 2023 | | TETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA |
| 12/12/22 | 10:04:20 | 12 Dec 2022 | | TETRIS PHARMA SERVICE AGREEMENT WITH SYNEOS HEALTH |
| 06/12/22 | 16:03:14 | 6 Dec 2022 | | Grant of LTIP Options and PDMR Dealing |
| 22/11/22 | 07:00:08 | 22 Nov 2022 | | ARECOGRANTED PATENT IN JAPAN AND SOUTH KOREA |
| 22/11/22 | 07:00:08 | 22 Nov 2022 | | ARECOR TO COMMENCE SECOND TRIAL WITH AT278 |
| 17/11/22 | 07:00:06 | 17 Nov 2022 | | Grant of AESOP Options and PDMR Dealing |
| 10/11/22 | 07:00:06 | 10 Nov 2022 | | SPECIALTY HOSPITAL FORMULATION COLLABORATION |
| 08/11/22 | 07:00:06 | 8 Nov 2022 | | Exercise of options and PDMR dealing |
| 01/11/22 | 07:00:06 | 1 Nov 2022 | | TETRIS PHARMA LAUNCHES OGLUO® IN GERMANY |
| 11/10/22 | 07:00:16 | 11 Oct 2022 | | Headline results from Phase I trial of AT247 |
| 20/09/22 | 11:03:16 | 20 Sept 2022 | | Arecor Presents Positive Data for AT278 at EASD |
| 08/09/22 | 07:00:11 | 8 Sept 2022 | | Interim Results for six months ended 30 June 2022 |
| 17/08/22 | 07:00:08 | 17 Aug 2022 | | Notice of Interim Results |
| 09/08/22 | 07:00:04 | 9 Aug 2022 | | ARECOR GRANTED EUROPEAN PATENTS |
| 05/08/22 | 15:33:04 | 5 Aug 2022 | | Holding(s) in Company |
| 05/08/22 | 11:52:33 | 5 Aug 2022 | | Holding(s) in Company |
| 04/08/22 | 14:09:35 | 4 Aug 2022 | | Holding(s) in Company |
| 04/08/22 | 14:08:55 | 4 Aug 2022 | | Holding(s) in Company |
| 04/08/22 | 10:45:02 | 4 Aug 2022 | | Holding(s) in Company |
| 04/08/22 | 08:55:53 | 4 Aug 2022 | | Director/PDMR Dealings |
| 02/08/22 | 16:52:04 | 2 Aug 2022 | | Arecor on Investor Meet Company Platform |
| 01/08/22 | 14:46:50 | 1 Aug 2022 | | Result of Placing |
| 01/08/22 | 07:00:11 | 1 Aug 2022 | | Proposed Acquisition of Tetris Pharma Ltd |
| 14/07/22 | 07:00:07 | 14 Jul 2022 | | BUSINESS UPDATE |
| 04/07/22 | 07:00:08 | 4 Jul 2022 | | ARECOR ANNOUNCES PRESENTATION AT EASD 2022 |
| 16/06/22 | 07:00:05 | 16 Jun 2022 | | ARECOR COLLABORATES WITH TOP GLOBAL PHARMA COMPANY |
| 23/05/22 | 14:19:57 | 23 May 2022 | | RESULT OF AGM |
| 23/05/22 | 07:00:05 | 23 May 2022 | | Arecor AGM statement |
| 18/05/22 | 08:00:01 | 18 May 2022 | | ARECOR TO HOST KOL WEBINAR |
| 28/04/22 | 07:00:06 | 28 Apr 2022 | | ARECOR PRESENTS AT278 PHASE I DATA AT ATTD MEETING |
| 27/04/22 | 17:08:08 | 27 Apr 2022 | | ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM |
| 27/04/22 | 07:00:09 | 27 Apr 2022 | | Arecor on Investor Meet Company Platform |
